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ABSTRACT 
The Luthando Neuropsychiatric HIV clinic was set up at Chris Hani Baragwanath Academic 
Hospital as an anti-retroviral roll out centre, specifically designed to provide anti-retroviral 
therapy to HIV positive patients with a psychiatric illness. Adherence to HIV treatment is 
essential for virological suppression, and non-adherence is a key factor in treatment failure. 
Research has suggested that psychiatric illness may negatively influence adherence to ART. 
Importantly, negative perceptions with regards to adherence may affect the decision to 
initiate ART in psychiatric patients.  
 
Attendance at clinic appointments is the first step in adherence, and has been found to be one 
of the most important predictors of medication adherence. Attendance at first clinic 
appointment is easily measurable in a limited resource setting, such as South Africa. The aim 
of this study was to examine the rate of attendance at the first clinic appointment post 
discharge from psychiatric hospitalization in HIV positive psychiatric patients initiated on 
ART as in-patients, and to determine which factors, if any may be related to clinic 
attendance.  
 
This study was a retrospective record review, conducted at Chris Hani Baragwanath 
Academic Hospital, at the Luthando clinic.  Patients that were initiated on ART as psychiatric 
in-patients, 18 years to 65 years of age from 1
st
 July 2009 to 31
st
 December 2010 and then 
discharged for follow up as out-patients at Luthando clinic were included in the sample. The 
primary outcome was attendance at the clinic post discharge from hospital. Socioeconomic 
and clinical data were also recorded and analysed, comparing attendant and non-attendant 
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groups. The rate of attendance was 79.59%. There were a number of similarities between the 
attendant and non-attendant patients in terms of demographic and clinical data.  The only 
significant difference between the attendant and non-attendant groups was disclosure of HIV 
status, and significantly fewer non-attendant patients had disclosed their HIV status to their 
treatment supporter (p = .01). Further research needs to quantify the significance of in-patient 
vs. out-patient initiation of ART, as well as to investigate the impact of a psychiatric 
diagnosis on attendance at ART clinics. Non-disclosure of HIV status needs to be further 
investigated and addressed in HIV treatment facilities in order to improve attendance.  
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CHAPTER ONE: INTRODUCTION 
1.1 Background  
The Luthando Neuropsychiatric HIV clinic (“Luthando clinic”) was set up at Chris Hani 
Baragwanath Academic Hospital (CHBAH) as an anti-retroviral roll-out centre, specifically 
designed to provide anti-retroviral therapy (ART) to HIV positive psychiatric patients. Prior 
to the release of the 2010 National Department of Health guidelines, HIV positive patients, 
with a psychiatric diagnosis, with CD4 counts below 200 cells/mm
3
, or an AIDS defining 
illness, were initiated as in-patients or out-patients on ART at the Luthando clinic. The 
Luthando clinic also provides support groups, counselling sessions, volunteer groups and 
occupational therapy groups.  
 
The Luthando clinic is situated within the psychiatry department at the CHBAH. Patients are 
referred to the Luthando clinic from the male and female acute psychiatric wards in the 
hospital, as well as from some medical wards within the hospital. Patients are also referred 
from the psychiatric outpatient department as well as other local community clinics for 
specialist management. Initially, the Luthando clinic also received referrals from other 
psychiatric hospitals such as Sterkfontein hospital, and Tara hospital, but these centres have 
now set up their own ART roll out programmes. Occasionally, patients are transferred in 
from another ART roll out site, such as the Peri-Natal HIV Research Unit (PHRU), or 
CHBAH‟s adult ART treatment centre, Nthabiseng, for continuation of ART, combining HIV 
and specialist psychiatric care. In addition to this, the Luthando clinic also provides care to 
some patients in hospice residential placements such as Mother Theresa.   
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Prior to initiation of ART, patients undergo an extensive medical workup, to exclude other 
treatable medical causes of the psychiatric presentation, including common opportunistic 
central nervous system (CNS) infections. What is a unique feature at the Luthando clinic is 
the tendency to initiate hospitalised psychiatric patients on ART, whilst still in hospital. If 
hospitalised psychiatric patients meet criteria for initiation of ART, they are sent to the 
Luthando clinic for review and are initiated on ART whist in the ward. They are subsequently 
discharged from hospital when mentally and physically stable, with an appointment date to 
follow up at the Luthando clinic within a month of discharge. There has been a general 
understanding that patients initiated on ART as in-patients have poorer outcomes than those 
initiated as out-patients. This has been supported by two South African studies showing high 
rates of loss to follow up (LTFU) in patients initiated on ART as in-patients (1,2). This 
perception is further evidenced by common practise in the medical wards at CHBAH, 
whereby in-patients are usually only initiated on ART as in-patients if their hospital stay is 
estimated to be prolonged, or if urgent treatment is thought to be lifesaving.  Furthermore, 
there is some evidence to suggest that the presence of a mental illness is associated with 
poorer adherence to treatment regimens (3,4,5,6,7,8).  
 
Consequently, negative perceptions with regards to rates of adherence, future clinic 
attendance and long term outcome may affect the decision to initiate ART in HIV positive 
psychiatric patients, especially in patients requiring hospitalisation. Attendance at the first 
clinic appointment post discharge from hospitalisation can be considered the first step in 
terms of long term retention in care and positive overall outcome of treatment. A larger 
evidence base will help guide future research and tailor treatment programs and guidelines to 
better serve this potentially vulnerable population. 
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1.2 Aim 
To examine the rate of attendance at the first clinic appointment post discharge from hospital 
in HIV positive psychiatric patients who were recently admitted to a psychiatric ward at 
CHBAH and initiated on ART as in-patients, and to determine which factors, if any, may be 
associated with clinic attendance.  
 
1.3 Study Objectives 
 To describe the demographic and clinical details of the sample population, including 
the age, gender, marital status, employment status, disability grant, level of education, 
psychiatric diagnosis and treatment, length of admission and time to follow up 
appointment, distance of residence from the clinic, substance use history, and the HIV 
stage, including the international HIV dementia scale (IHDS) score. 
 
 To determine the rate of attendance at the first clinic appointment after discharge from 
hospital of patients initiated on ART as in-patients in the psychiatric wards at 
CHBAH   
 
 To compare attendant versus non-attendant patients, determining which factors if any 
may be associated with attendance or non-attendance at the first clinic appointment. 
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1.4 Hypothesis 
HIV positive psychiatric patients who are initiated on ART as in-patients will return for the 
first follow-up appointment after discharge from hospital.    
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CHAPTER TWO: LITERATURE REVIEW 
2.1 HIV and Psychiatry in South Africa 
The HIV epidemic has changed the face of psychiatry in South Africa, bringing with it a 
multitude of challenges for the mental health care professional. HIV is known to have a 
causative role in mental illness. This can be due to the direct effects of the virus on the central 
nervous system; the effects of opportunistic infections; the psychological effects of the virus, 
largely related to the stigma and social consequences of HIV infection; as well as psychiatric 
side effects of treatment (9,10). Mentally ill patients may be co-morbidly infected with HIV, 
with some authors suggesting an increased risk of HIV infection in mentally ill patients (11). 
 
With the advent of ART and the widespread introduction of ART into resource poor 
environments including the South African public sector, there is a need to examine factors 
affecting long term outcome in all patients infected with HIV. This includes those who are 
HIV positive who present to psychiatric services.  
 
The issue of non-adherence is particularly important in HIV medicine, as well as in 
psychiatry and impacts directly on long term outcomes. Non adherence to ART has been 
associated with decreased CD4 count, increased viral load, higher mortality and morbidity 
and overall poorer quality of life (3,12). What is uniquely challenging in managing HIV as a 
chronic illness is the direct relationship between poor virological suppression and the 
development of resistant strains of HIV. Adherence to ART is vital for successful virological 
suppression in HIV infected individuals (13). In a Ugandan study in 2004, Richard et al (13) 
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found that “rapid emergence” of resistance to ART was directly associated with decreased 
compliance to medication.
 
The development of resistance to first line ART necessitates 
second line therapy which may be expensive and less readily available in a resource poor 
environment (3,14). 
 
It is not only in the field of HIV medicine that adherence to treatment has been shown to be a 
vital determinant of long term outcome. In psychiatry, the importance of adherence to 
treatment is made clear when examining the effects of non-compliance to psychiatric 
treatment, in terms of patient morbidity, mortality as well as the increased cost of treatment 
(15,16). Bearing in mind the impact of poor adherence on HIV outcomes and on psychiatric 
prognosis, improved adherence is a crucial target in the management of the psychiatrically 
unwell HIV positive patient. 
 
2.2 Adherence to ART in the Mentally Ill 
Negative perceptions regarding the ability of the mentally unwell to adhere to treatment 
regimens may impact on access to lifesaving ART treatment in this population group (17).  
However, in a study from the United States (US), Heimelhoch et al (18) found that patients 
with a psychiatric disorder were 37% more likely to receive ART than controls without a 
psychiatric disorder in an integrated HIV and psychiatric treatment centre. To my knowledge, 
this relationship has not been studied in a resource limited setting and findings may 
significantly differ with challenges such as unemployment, poverty, understaffing at clinics 
and resultant difficulties with follow-up services and individual patient monitoring. In 
practice there is a general perception that psychiatrically unwell patients in the South African 
setting would have difficulty adhering to ART treatment (19). 
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The evidence with regards to adherence in the psychiatrically unwell HIV positive population 
is currently limited, with most research emerging from the (US), and no significant 
contributions from resource poor environments. In their review of common mental health 
problems and ART adherence, Nel and Kagee, (3) found overall a reciprocal relationship 
between the severity of the psychiatric presentation and ART adherence. A similar 
relationship has been shown between adherence and HIV associated neurocognitive disorder 
(HAND) (4). While depression seems to be a risk factor for poor adherence, studies 
examining serious mental illness and adherence have been inconsistent (3,8,20,21,22). 
 
2.2.1 HIV related neurocognitive disorder  
HIV dementia (HAD) specifically has important implications when looking at adherence, as 
dementia has been shown to be a negative predictor for adherence in a clinical setting (4,5). 
Ettenhofer et al (4) found a reciprocal relationship between antiretroviral adherence and 
cognitive ability. Specifically, they found the most important predictors of medication 
adherence to be executive function, learning and memory (4). Similarly, Hinkin et al (6) 
found an association between executive function, memory and attention and poor adherence 
in HIV positive individuals in Los Angeles. It would be expected that a diagnosis of HAND 
would negatively affect clinic attendance, largely related to memory deficits in terms of 
keeping appointments, although to my knowledge there are no studies examining clinic 
attendance in patients with a diagnosis of HAND in a South African setting.  
 
P a g e  | 8 
 
In a resource poor environment, an important tool used to screen for HIV associated dementia 
is the International HIV dementia scale (IHDS) (23). This has been validated in Uganda and 
the USA as an appropriate screening tool for HAD with a cut off value of 10 (23). Recently, 
Joska et al (24), in a South African study published in 2011, found the IHDS to be less 
sensitive in the South African sample group than the earlier results from 2005 when using the 
cut off value of 10, and suggested a cut off of 11 in the South African population. In clinical 
practice, the IHDS is used as a screening tool for HAND, and a cut off value of 10 continues 
to be used in the South African setting.  
 
2.2.2 Serious mental illness and ART adherence 
Serious mental illness (SMI) is a term usually referring to the American Psychiatric 
Association‟s Diagnostic and Statistical Manual (DSM) diagnoses of schizophrenia, bipolar 
disorder, and major depressive disorder with psychotic features (21). Factors inherent to the 
diagnosis of a serious mental illness may negatively influence adherence. Schizophrenia, for 
example, is characterised by positive features such as delusions and hallucinations, 
disorganised speech and behaviour; as well as negative features including cognitive slowing 
and avolition (5). These features associated with schizophrenia, if not controlled, may 
negatively influence a patient‟s ability to adhere to a treatment regime (21). It is also possible 
that these factors would affect clinic attendance. 
 
Heimelhoch et al (20) examined a cohort of HIV infected individuals in the US and focused 
in on the relationship between having a serious mental illness and discontinuation of highly 
active combined antiretroviral therapy (HAART). They found that patients with a SMI were 
significantly “less likely to discontinue HAART” in the first 2 years of treatment compared 
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with patients with no history of mental illness. Also, among the patients with a psychiatric 
diagnosis, those who had more mental health care visits were “less likely to discontinue 
HAART”, suggesting that successful treatment of SMI improves adherence, and that more 
vigilant follow-up of those with a mental illness may be needed to ensure retention in care 
(20). Although these findings seem to suggest a favourable outcome in terms of adherence in 
a first world setting for HIV positive patients with a SMI, Wagner et al (21) investigated 
ART adherence in patients with HIV and a SMI and found a mean adherence of only 66% 
using electronic monitoring caps. They recommended that further research should continue to 
investigate issues relating to adherence in HIV positive patients with a SMI (21).   
 
There have been several studies specifically examining the relationship between bipolar 
disorder and adherence to ART. Walkup et al (22) examined the relationship between ART 
adherence and bipolar medication adherence and found that patients with bipolar disorder 
were more likely to be adherent to ART in the month after filling their bipolar medication 
scripts, suggesting that better control of bipolar disorder increases adherence to ART. Moore 
et al (8) compared HIV positive patients with bipolar (HIV+/BD+) and HIV positive patients 
without bipolar (HIV+/BD-) and found that those with a dual diagnosis were significantly 
less likely to be adherent. Evidence thus far suggests a significant negative impact of bipolar 
diagnosis on adherence, but also suggests that successful treatment of bipolar disorder may be 
associated with improved adherence.  
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2.2.3 Depression and ART adherence 
Depression has been consistently reported as important in ART adherence. Factors associated 
with depression, which are important in determining patient adherence to treatment, include 
poor memory, anhedonia and decreased concentration (3,5). In a meta-analysis of the 
available literature, DiMatteo et al (25) examined adherence to treatment of a medical 
condition and found that depressed patients were three times more likely to be non-compliant 
than non-depressed patients. Similar values have been reported for HIV specific adherence 
and depression (3). Do et al (7) found the presence of depression to be significantly related to 
non-adherence in an HIV treatment setting in Botswana. Depression would most likely affect 
the ability to adhere to appointments in an ART treatment program, with Kunutsor et al (26) 
citing depression as a reason given by patients for missing appointments at an ART clinic. 
 
2.2.4 Substance abuse and ART adherence 
Uldall et al (5) reviewed the literature on mental illness, chemical dependency and HIV 
adherence and found that substance use was common among HIV positive individuals, and 
that substance use has been associated with poorer adherence to HIV medication. Do et al (7) 
found an association between on-going alcohol use and non-adherence in a Botswanan 
population. In their review of common mental health problems and ART adherence, Nel et al 
(3) recognised the importance of substance abuse, often co-morbid with other mental health 
care problems and the shared impact on adherence to ART.  They also listed factors 
associated with substance abuse that negatively influence adherence, such as problems with 
memory and concentration (3).  
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2.2.5. Dual stigma - HIV and mental illness 
Stigma has been consistently cited as a reason for non-disclosure of HIV positive status by 
HIV positive individuals to friends or family members (27,28). MacQuarrie et al (29) 
summarized their findings on review of the literature with regards to HIV related stigma and 
discrimination. They found that HIV related stigma is highly prevalent and negatively 
influences testing, treatment and adherence (29). Rintamaki et al (30) found that non 
adherence to medication was significantly more likely in people with high HIV “stigma 
concerns”. (30) 
 
Added to this, stigma is overwhelmingly present in psychiatry and has also been found to be 
associated with non-adherence. Gray (31) summarises the issue of stigma in psychiatry in her 
article published in 2002, where the consequences of stigma are far reaching, including 
concealing of mental illness and delays in treatment, social rejection as well as hopelessness. 
Sirey et al (32) found that perceived stigma was associated with treatment discontinuation in 
elderly adults with depression. They defined perceived stigma as the “belief that most people 
will devalue and discriminate against individuals who use mental health services and/or have 
a mental illness”. (32, p.479) A further issue and area of concern especially in the HIV 
positive mentally unwell, is that of discrimination in terms of access to health care for 
physical conditions as a result of stigma (31).   
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2.3 Other Factors Related to Adherence in HIV Management 
2.3.1 Disclosure of HIV status 
Do et al (7) found a significant association between failure to disclose HIV positive status to 
a partner and non-adherence to ART in a HIV positive cohort in Botswana. In line with this 
Charurat et al (33) in a large Nigerian study found an association between increased 
adherence and disclosure of HIV status to a family or friend. Also, in related research, 
Ramadhani et al (34) examined “incomplete adherence” and “virlogical failure” in an HIV 
positive sample in Tanzania and found disclosure to friends or family to protect against 
virological failure.  
 
2.3.2 Treatment supporter 
A Ugandan study in 2001 looked at improving clinic attendance and treatment adherence 
through the presence of a treatment supporter (35). They measured clinic attendance for 
refills and measured adherence using monthly pill counts.  Participants with a treatment 
supporter had a greater likelihood of being treatment adherent, and being on time for their 
clinic appointments. A major limitation of this study was the lack of objective measures such 
as repeat viral loads in support of monthly pill count as a measure of adherence (35).  
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2.3.3 In-patient initiation of ART in the mentally ill 
To my knowledge, there are no studies examining out-patient adherence or retention in care 
after in-patient initiation of ART in mentally ill patients. Two South African studies have 
linked in-patient initiation of ART with increased LTFU in non-psychiatric HIV positive 
individuals.  Eshun-Wilson et al (2) found a high rate of loss to follow up of 35% in 
hospitalised patients initiated on ART, defining LTFU as no OPD clinic attendance for three 
months. In line with this, Boyles et al (1) found that initiating ART as an in-patient was an 
independent predictor of loss to follow up, with an overall loss to follow up of 6.5%, which 
was defined in their study as no patient contact for more than six months at the end of the 
study period.   
 
De Socio et al (36) reported a good overall treatment response in Psychiatric HIV positive 
patients initiated on ART in hospital in an Italian setting, however, this study was conducted 
is in a long term residential placement setting for the mentally unwell with very close 
supervision of treatment and does not address long term adherence, particularly in the out-
patient setting.  
 
2.4 Measures of Adherence 
Adherence to ART can be evaluated by a number of methods, some more reliable than others 
including self-report, electronic monitoring caps, biological markers (viral load and CD4 
count), pill counts and clinic attendance (5). Practically, in a clinic setting, an important 
marker of adherence to medication is attendance at clinic follow up appointments (21). 
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Attendance is the first step in adherence and without attendance a patient cannot actually take 
medication. Wagner et al (21) used electronic monitoring caps and found that attendance at 
clinic follow-up appointments was strongly associated with adherence to medication, and was 
easily measurable. Similarly, Kunutsor et al (26) found a strong association between clinic 
attendance and adherence to ART, examining patients who had defaulted one clinic 
appointment. The authors suggested that monitoring clinic attendance in a resource–poor 
environment may be a useful tool to assist in early identification of those at risk of non-
adherence (26).  
  
2.5 Medication Adherence and Clinic Attendance 
Although it has been found that medication adherence and clinic attendance are intricately 
linked, it should be remembered that a patient may attend the clinic but not be adherent to 
medication, for example a patient who regularly attends the clinic but does not take the 
medication on a daily basis at home (21,26). Any record of patients who are non-attendant at 
clinic appointments includes those who have defaulted treatment, but may also include those 
patients who have died, or transferred to an alternative treatment site (37). Geng et al (37) 
investigated the outcome of a sample of patients who were lost to follow up in an ART clinic 
in Uganda. Of the sample of 128, 111 were traced and 48 directly interviewed. Of those 
traced, 23 were found to have died, mostly due to HIV related illness.  Of those still alive, 
who were successfully traced and interviewed, 83% reported they were attending another 
clinic, while 71 % reported that they were currently receiving ART from another clinic (37). 
In line with this, transfer to another clinic site was found to be an important reason for non-
attendance in a follow up of patients recorded as “lost to follow up” (38). Peltzer et al (39) 
prospectively examined the characteristics of HIV positive patients in Kwa Zulu Natal who 
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were lost to follow up 6 - 12 months after initiation of ART. Of those that were initially 
categorised as lost to follow up, 46% were found to be deceased (39).   
 
In their review of psychiatric clinic appointment non-attendance, Mitchell and Selmes (16) 
report that psychiatric appointment non-attendance is closely related to non-adherence to 
medication. Sparr et al (40) conducted a follow up of psychiatric clinic non-attendant patients 
and found that 73% of missed appointments were rescheduled within two weeks of initial 
appointment date, and that reasons given for non-attendance included patient error, 
forgetfulness, or confusion regarding the date of the appointment. Reports of death as a 
reason for psychiatric clinic non-attendance seem far less frequent than what is reported in 
follow-up investigations of HIV clinic non-attendance. Pang et al (15) reported that 6% of 
patients missing psychiatric out-patient clinic appointments who had been successfully traced 
had subsequently died and thus missed appointments. There was also a high rate of re-
admission for psychiatric reasons among non-attendant, leading to missed appointments (15). 
 
Most research focusing on clinic non-attendance is limited to populations with either HIV or 
mental illness, with no literature to my knowledge examining clinic attendance in those 
patients who have both an HIV diagnosis and a mental illness.   
 
2.6 Measuring Non-Attendance in the Research Setting 
The term LTFU is commonly used in HIV related research; however there is no universal 
definition of the term. Non-attendance is often recorded as LTFU, meaning anything from 
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failure to attend the next scheduled appointment, to failure to attend the clinic within a certain 
time frame, which can range from 30 days to 36 months (41). Chi et al (42) aimed to provide 
evidence based universal definition of the term LTFU for HIV-related research, in their 
multisite study published in 2011 (42). Loss to follow up usually refers to a time interval, 
which varies between centres, from the last appointment in which period there is no follow up 
(42). This time interval was examined in the study by Chi et al (42), keeping in mind that a 
short time interval, would yield a high level of sensitivity but a low specificity, in that 
patients who do not attend early may still attend at a later stage, and a long time interval may 
miss patients who become non-attendant at a later stage, so have a lower sensitivity but a 
higher specificity. They examined data across 111 ART treatment facilities in Asia, Africa 
and Latin America to determine a time interval for which there was optimal sensitivity and 
specificity, and found a period of 180 days to be most reliable, with the least number of 
“misclassifications” when compared to 12 month follow up (42). This is in contrast to prior 
recommendations by Chi et al (41) in an earlier study involving a smaller cohort in Uganda, 
where the authors suggested a cut-off point of 60 days in defining LTFU (41). While there 
has been an attempt to standardise definitions of LTFU, in his editors summary of the article 
published by Chi et al in 2011, Bartlett (42, see editors summary) suggested that in certain 
contexts, “national, regional and local definitions of LTFU may be more appropriate” when 
taking into consideration “the wide range of best performing definitions among facilities”. 
(42, p.12)  
 
The rate of non-attendance at the first clinic follow-up appointment post discharge from 
psychiatric hospitalisation has been investigated by several authors. Kruse et al (43) 
examined factors associated with attendance at the first clinic appointment post psychiatric 
hospitalisation. Similarly, Crompton et al (44) examined predictors of missed first clinic 
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appointment at community mental health care centres after psychiatric hospitalisation. In both 
of these US based studies; attendance at the first clinic appointment post discharge from 
hospitalisation was the primary outcome measure. To my knowledge, there are no similar 
studies in HIV positive patients, with a focus on the first clinic appointment post discharge 
from hospitalization, in patients with or without mental illness.      
 
2.7 Importance of Attendance at HIV Clinic Appointments 
Non-attendance at HIV clinic appointments has been found to be associated with poor CD4 
response, failure to achieve virological suppression, increased risk of death and increased risk 
of loss to follow up (45). Appointment non-attendance, including interrupted care, has also 
been found to be a significant predictor of higher viral loads and lower CD4 counts (46,47). 
Mugavero et al (48) found a significant increase in mortality rate in HIV positive patients 
missing appointments in the first year of treatment. “Timely” clinic attendance has recently 
been shown to be associated with decreased viral loads and lower levels of viral resistance 
(49). 
 
2.8 Rate of Non-Attendance at HIV Clinics 
In the South African context, examining attendance at out-patient ART clinics, Brennan et al 
(45) found that 35% of patients missed at least one visit in the first six months of treatment. 
There are no South African studies examining the rate of clinic attendance at the first out-
patient clinic appointment in patients initiated on ART as in-patients. However there are 
several studies reporting longer term LTFU, with variable definitions of the term LTFU. 
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Eshun-Wilson et al (2) found that 35% of patients initiated on ART as in-patients did not 
return to the clinic for a three month period and were therefore LTFU. In line with this, 
Boyles et al (1) reported an overall loss to follow up of 6.5%, which was defined in their 
study as no patient contact for more than six months at the end of the study period. 
 
Bofill et al (50) investigated the demographic and psychosocial factors associated with 
appointment attendance among HIV-positive out-patients in Miami, Florida, and found that 
during the study period 27.9% of scheduled appointments were missed. Mugavero et al (48) 
examined missed visits and mortality in out-patient care in HIV positive individuals, and 
found that within the first year of treatment, 60% of patients had missed a clinic visit.   
 
2.9 Factors Associated with Non-Attendance at HIV Related 
Appointments 
Catz et al (51) looked at HIV medical appointment attendance in the USA and showed that 
out-patient appointment non-attendance was associated with “younger age, minority status, 
less severe illness and lower perceived social support”. (51, p.361). Pregnancy was associated 
with increased risk of loss to follow up in the South African setting, and HIV positive women 
have been “found to miss more medical appointments than men” (1) (52, p.473). Isrealski et 
al (52) also found that increased age and increased income were associated with increased 
attendance of medical out-patient appointments. Other factors reported as reasons for non-
attendance include work and child care related problems, financial difficulties, lack of 
transport to the clinic, family and religious beliefs regarding treatment as well as feeling too 
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sick to return to the clinic (37). In line with this, food assistance programs as well as “free” 
treatment programs have been associated with greater attendance (38,53). 
 
In their letter to the editor published in Psychiatric Services in 2007 by Breen et al (54) 
examined adherence to treatment in poorer countries and mention factors unique to low and 
middle income countries, often associated with “rapid urbanisation”. Breen et al (54) 
interviewed families of patients living with mental disorders in poor South African 
communities. They found that reasons given for poor adherence included logistical problems 
such as queuing in the dark from early in the morning outside the clinics and long queues to 
collect medication. Some of the patients that were interviewed reported taking incorrect doses 
in order to decrease the frequency of clinic visits for this reason. There was also a reported 
fear of mugging and physical attack associated with queuing and waiting for clinic 
appointments in the dark (54). This would lead to a decrease in clinic attendance in this 
population.  
 
2.10 Importance of Attendance at Psychiatric Clinic 
Appointments 
In a prospective outcome study examining psychiatric patients who regularly missed out-
patient appointments, Pang et al (15) found that there was a significant increase in 
hospitalisation and death among patients who dropped out of treatment. It is not clear if these 
patients were hospitalised or died before or after their recorded missed appointments. 
Killaspy et al (55) prospectively followed a cohort of patients attending an out-patient 
psychiatric clinic. They found that in follow up patients, non-attenders were more likely to 
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have subsequently been admitted to hospital than attenders, but were also more likely to 
default further appointments and to drop out from treatment. Non-attenders were more 
psychiatrically unwell and had poorer social functioning (55). Essentially, evidence has 
shown a need for increased vigilance regarding follow-up of those who miss psychiatric out-
patient appointments. 
 
2.11 Rate of Non-Attendance at Psychiatric Clinic 
Appointments 
In a retrospective review published in 2002, Kruse et al (43) measured rates of attendance at 
the first clinic appointment after discharge from a psychiatric hospital in the United States, 
and found that 18% of their sample did not attend the follow up appointment. This was in line 
with a finding by Thapar and Ghosh in 1991 (56), who studied rates of non-attendance at a 
psychiatric clinic in Wales and defined non-attendance as any new or follow-up patients who 
did not arrive for a clinic appointment without making a cancellation. The overall non-
attendance rate for the study period was 17.5 % (56). However, Crompton et al (44) found a 
high rate of 64% non-attendance at the first scheduled clinic appointment post discharge from 
psychiatric hospitalisation. 
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2.12 Factors Associated with Non-Attendance at Psychiatric 
Clinic Appointments 
In psychiatric appointment attendance, young age, race, area of residence and limited family 
support have all been found to be associated with non-attendance (43,50,57). Non-attendance 
was also previously associated with more severe mental illness (55). Centorrino et al (58) 
found personality disorder diagnosis, acute stage of illness, and higher level of education to 
be associated with attendance. 
 
Kruse et al (43) found that appointments less than 2 weeks after discharge from hospital were 
more likely to be attended in patients discharged from psychiatric hospitalisation.  Reliance 
on public transport was found to be associated with non-attendance in a first world setting 
(56).  
 
Gonzalez et al (59) found that attendance at mental health appointments improved when there 
was a perception of a collaborative relationship with the physician. Other factors predicting 
missed appointments in the mental health care settling include not having a regular out-
patient doctor and leaving hospital against advice of the treating team (44). Level of 
satisfaction with the clinic and perceived need for treatment were associated with 
appointment attendance (56). Attendance was also found to be higher if the visit was for 
psychotherapy as opposed to psycho-pharmacotherapy (58). 
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2.13 Summary of Literature Review 
Adherence to ART is vital for successful treatment of HIV infected patients. Psychiatric co-
morbidity raises concerns with regards to a patient‟s ability to adhere to ART. Evidence has 
shown a link between psychiatric conditions and poorer overall adherence to ART. 
Psychosocial factors such as dual stigma have also been shown to influence adherence 
behaviours. Clinic attendance has previously been shown to be significantly associated with 
medication adherence and has been easily measured in a resource poor setting. A number of 
factors have been linked over the years with clinic attendance, but factors have varied from 
study to study, between conditions and with each population studied.     
 
Although the issue of adherence in HIV positive mentally unwell patients has been 
previously examined, and there have been several studies looking at attendance at both 
psychiatric and HIV out-patient clinics, there were no studies examining attendance in the 
dual diagnosis population, those with HIV and a psychiatric presentation. While there are a 
few American studies focussing on out-patient first clinic appointment attendance post 
psychiatric hospitalisation, there are no similar South African studies. There are also no 
studies looking at out-patient first clinic appointment attendance after in-patient initiation of 
ART in psychiatric patients.  
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CHAPTER THREE: METHODOLOGY 
3.1 Study Design, Sample Size and Population 
This study was a retrospective record review, conducted at Chris Hani Baragwanath 
Academic Hospital, at the Luthando clinic. The study group included all HIV positive (ART 
naïve) mentally ill patients between the ages of 18 and 65, that were initiated on ART as in-
patients, while admitted to a psychiatric ward at CHBAH and subsequently discharged from 
CHBAH, to follow up for continued ART and psychiatric treatment at the Luthando clinic.  
 
A list was obtained of all the new patients attending the Luthando Neuropsychiatric clinic 
during the period 1 June 2009 – 31 December 2010, including the date of the first 
appointment at the Luthando clinic. The total number of new patients in this period was 388. 
This study period was chosen as it was felt there would be a significant number of patients 
initiated on ART as in-patients in this period. The clinic had been increasingly initiating in-
patients on ART since its inception in 2008. Data collection began in early 2011. The 
Medicom Database is the computer system at CHBAH which holds the records of patient 
registration details, date of admission and discharge as well as hospital number.  This 
database was scanned to determine admission and discharge dates for each patient. All 388 
Luthando clinic files were obtained and examined to determine the date of initiation of ART. 
This information was examined together with the admission and discharge details obtained 
from the Medicom database, and it was determined if a patient was an in-patient or an out-
patient at the time of their first clinic appointment and at the time of initiation of ART.   
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There were 98 patients included in the final data analysis. This sample size was determined 
after reviewing all new appointments at the clinic between 1 July 2009 and 31 December 
2010, and determining which patients met inclusion and exclusion criteria. The sample was 
much smaller than initially anticipated as it was believed that there was a higher percentage 
of the total 388 new appointments that were in-patients and would fulfil study inclusion 
criteria.  
 
3.2 Inclusion Criteria 
Patients were included in the study if they met all of the flowing criteria: 
 They were HIV positive and ART naive prior to referral to Luthando 
Neuropsychiatric Clinic 
 They were seen for a first appointment at the Luthando clinic during the period 1 June 
2009 – 31 December 2010 and subsequently initiated on ART during this same period  
 They were in-patents at CHBAH at the time of initiation of ART, admitted in a 
psychiatric ward  
 They were discharged from a psychiatric ward at CHBAH with recommendations to 
follow up at the Luthando Neuropsychiatric clinic 
 They were between the ages of 18 and 65 
 
3.3 Exclusion Criteria 
Patients were excluded from the study if:  
 They were seen at the clinic but not initiated on ART  
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 They were discharged with instructions to follow up at a clinic other than Luthando 
clinic  
 They were seen as in-patients during the study period but initiated on ART as out-
patients  
 They were transferred to another hospital and not discharged from CHBAH directly.  
 They had been initiated on ART elsewhere and were subsequently admitted, or had 
defaulted treatment and were admitted, and were thus re-commenced on treatment 
whilst admitted  
 They were lost to follow up whilst in hospital, and therefore not discharged with a 
Luthando appointment. This would have occurred, for example, if a medically unwell 
patient who deteriorated physically whist in the psychiatric ward was then transferred 
to the medical department for further management. The reason for exclusion was that 
the patient was most likely subsequently discharged from the medical department of 
the hospital without a Luthando appointment and so no follow up was arranged.  
 They were transferred to a Life Esidemeni placement facility with no recorded follow 
up appointment scheduled. Life Esidemeni facilities are contracted by the government 
to provide long term residential care to public sector psychiatric patients who are 
unable to be managed within the community. 
 
3.4 Data Collection 
All data for the study were recorded on a specific data source sheet, numbered in order of 
collection, not including the patient‟s name or hospital number. Information was manually 
recorded from each relevant Luthando Neuropsychiatric clinic file, after determining if the 
patient met inclusion and exclusion criteria as stated above, specifically that the patient was 
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an in-patient in a psychiatric ward at CHBAH at time of initiation of ART. If information was 
incompletely recorded in the Luthando Neuropsychiatric clinic file, then the general 
psychiatric clinic file was obtained, and if this was not sufficient, then the CHBAH official 
admission record was obtained to fill in the missing data. 
 
At times, on review of the Luthando file, it was clear that the patient was admitted to hospital, 
but this information did not correlate with the Medicom Database movement register, likely 
due to input error in the database or incorrectly recorded hospital number. In these cases, the 
hospital file was requested from patient registry. The manual admission and discharge dates 
recorded on the front of the hospital file were used to confirm that the patient met the criteria 
for the study and to calculate the length of admission.   
 
Demographic data was obtained from the Luthando clinic file. The Luthando clinic file 
contains a basic data sheet which is completed at the initial visit including information on 
age, gender, address, marital status, employment status, disability grant status, presence of a 
treatment supporter and alcohol unit consumption. There is a separate sheet, containing HIV 
related data such as stage of infection and previous exposure to HAART. In addition to this, 
on each visit to the clinic, an appointment sheet is completed, with variable data depending 
on the treating doctor‟s clinical notes, usually including the date of the visit, admission to 
hospital, diagnosis, treatment, and complications. The follow-up appointment date is also 
recorded on this sheet. In addition to this, a referral sheet is often found in the file with basic 
information from the treating ward doctor referring the patient to the Luthando clinic for 
initiation of ART 
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3.4.1 Primary outcome - attendance 
The primary outcome was attendance at first clinic appointment after discharge from hospital. 
This appointment date was recorded on the last appointment sheet completed during the in-
patient management of the patient, or on the discharge summary, usually found in the 
psychiatric file or the CHBAH file. The appointment sheet for the next appointment after 
discharge was located.  
 
The patient was classified as attendant (attending their appointment) if the date given before 
discharge and the next recorded visit were the same, partially attendant if the next visit was 
within one month of the appointment date, and non-attendant if there was no follow up within 
one month of appointment date. For all future analysis, attendant and partially attendant are 
grouped together as “attendant”. This grouping was decided on because patients are usually 
discharged from hospital with one month supply of their medication, and so if attending 
within one month of the given date, then it is still possible that they are adherent to 
medication. Also, some patients were discharged just before the next follow up appointment 
date recorded in the Luthando file, and it is possible they were told by the discharging doctor 
or ward to follow up “in a month” at the Luthando clinic, and not given the specific date in 
the file. On several discharge summaries, it was stated that the patient should follow up at 
Luthando, but the date was not specified, suggesting that the patient may not have been aware 
of the appointment date. 
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3.4.2 Secondary outcomes  
3.4.2.1 Length of admission and time to follow up 
appointment 
The data source sheet also recorded the date of admission and discharge, which was used to 
calculate the length of admission and time from discharge to follow up appointment.  
 
3.4.2.2 Socio-demographic variables 
Data was collected on demographic details; age (at the time of the first appointment), gender, 
marital status, employment status and level of education.  Distance from the CHBAH to the 
furthest point of each major Soweto area was measured “as the crow flies” using Google 
maps, and areas were grouped together by estimated distance. It was usually documented in 
which area the patient lived, but not necessarily the exact address.  
 
3.4.2.3 Psychiatric diagnosis 
Data on psychiatric diagnosis was recorded from the clinical notes in the Luthando file, or if 
not recorded in the Luthando file, then from the CHBAH file or the psychiatric out-patient 
clinic file. No validated diagnostic scales were used as the diagnosis was always a clinical 
diagnosis and this was a retrospective review. Diagnoses were categorised based on the DSM 
IV TR, although often no differentiation was made in terms of bipolar disorder I and II in the 
clinical notes, and so a diagnosis of bipolar was recorded. For statistical analysis, diagnoses 
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were loosely grouped into two groups due to the small numbers involved; “Primary 
psychiatric illness” (schizophrenia, schizoaffective disorder, bipolar disorder, not specified I 
or II, major depressive disorder, and substance induced psychotic disorder), and “psychiatric 
illness due to general medical condition” (HIV or other). The psychiatric diagnosis most 
often included a differential diagnosis, and all of the differentials were recorded on the data 
sheet, in no particular order. 
 
3.4.2.4 Current psychiatric treatment 
Current in-hospital treatment for the psychiatric symptoms was recorded from the Luthando 
file and simplified into mono-therapy vs. poly-therapy, depending on the number of 
psychotropic used. Benzodiazepines were not included as treatment as most patients receive 
short term benzodiazepines whilst in the ward regardless of diagnosis.   
 
3.4.2.5 Substance use history 
Substance use history was seldom recorded in the Luthando file, and this information was 
taken from the discharge summary or from the initial clerk of the patient in the CHBAH file, 
relying on the patients self-report of substance use, or the collateral information reporting 
substance abuse/use, with no additional screening done for substances, and no validation in 
terms of categorising use, abuse or dependence.   
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3.4.2.6 IHDS score and stage of HIV infection 
The cut off value for IHDS for screening for HIV associated dementia was taken as 10 as that 
is the currently accepted value (23). The IHDS was not routinely recorded in the clinic file 
but was done at the first clinic visit, or follow up visits, if a neurocognitive deficit was 
clinically suspected, or in the ward if clinically deemed to be necessary. The World Health 
Organization (WHO) stage of HIV infection was recorded in the initial Luthando record for 
each patient. 
 
3.4.2.7 Disclosure of HIV status 
Disclosure of HIV status was also difficult to measure, as all patients had a treatment 
supporter, but, on review of the clinic file, had not necessarily disclosed their HIV status to 
the treatment supporter. The treatment supporter is chosen by the patient prior to initiation of 
ART. The treatment supporter is usually a family member or close friend who will assist with 
reminders to attend the clinic and encouragement to continue with treatment. At the Luthando 
clinic the presence of a treatment supporter was enquired about at first visit, prior to initiation 
of ART. Often, the clinician had recorded in the file “disclosed” or “not yet disclosed”, 
however, it was often not recorded if the treatment supporter was aware of the diagnosis and 
this was then recorded as unknown. This additional clinical note regarding disclosure could 
suggest that while the patient may have had someone (the treatment supporter) who was 
aware that the patient was attending a clinic for a medical condition, the treatment supporter 
may not have been aware of the diagnosis of HIV. Alternatively, it could have meant that the 
patient had identified someone to be a “treatment supporter” but had not yet disclosed their 
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HIV positive status to that identified person. ART was commenced whether or not disclosure 
of HIV status to the treatment supporter was confirmed. 
  
3.5 Statistical Analysis 
Data was recorded in Microsoft Excel and statistical analysis performed using the GraphPad 
Instat3 program, which was downloaded off the internet. Two by two contingency tables 
were constructed for categorical variables, comparing each categorical variable with 
attendance at follow up appointment. Categorical data were analysed using Fisher‟s exact test 
in order to obtain a p-value for statistical significance. Fisher‟s exact test was used as the 
sample size was small and the chi squared test would have generated incorrect p-values. 
Continuous variables were described using means and standard deviations, and statistical 
significance was calculated using the unpaired t-Test for the “age” variable, and the Mann-
Whitney test for the three non-parametric continuous variables. A significance level of 5% 
was used for all tests. Variables were grouped for analysis in the categories “marital status”, 
“psychiatric diagnosis” and “disclosure of HIV” status due to the small number in each 
specific sub-category.  
 
3.6 Postgraduate Committee and Ethics Committee Approval 
The study was submitted to the University of the Witwatersrand‟s Human Research Ethics 
Committee (HREC), and approval was granted unconditionally. Due to the retrospective 
nature of the study direct informed consent was not necessary. The names and personal 
identifying details of all the patients in the study remain anonymous and were not recorded 
on the data sheets.  
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Permission from the head of the Department of Psychiatry at CHBAH and the management at 
CHBAH was obtained to conduct research and access the Medicom database of the wards 
and at Luthando Clinic.  
 
Postgraduate research committee approval of the initial research protocol was obtained and 
all corrections to the initial research proposal were reviewed by the research supervisor and 
approved by the Postgraduate research committee. The Post graduate research committee also 
recommended a change of title, which was subsequently submitted and approved.  
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CHAPTER FOUR: RESULTS  
4.1 Sample Characteristics 
Of the 388 new patients seen at the clinic from 1 July 2009 to 31 December 2010, 155 were 
in-patients at the time of the first clinic appointment, and of that number 131 were initiated 
on ART as in-patients. The 24 in-patients who were not initiated on ART as in-patients were 
not eligible for inclusion in the study: two patients refused ART, and had capacity to make 
that decision; two patients were found to be HIV negative and had been inappropriately 
referred to the clinic; one patient had a high CD4 count and so did not qualify for ART 
initiation; a further 19 patients were not initiated on ART whilst admitted to hospital, but 
rather discharged with a plan to initiate ART as out-patients.  
 
Of the 131 patients initiated on ART as in-patients, 33 were excluded from further analysis: 
one patient was transferred to another hospital and not discharged from CHBAH directly; 
five patients were discharged to follow up at a community clinic or in a separate province; 22 
patients had been initiated on ART elsewhere and were subsequently admitted, or had 
defaulted treatment and were admitted, and were thus recommenced on treatment whilst 
admitted; four patients were also excluded as they were lost to follow up whilst in hospital 
after transfer to the medical department for further management and were therefore not 
discharged with a Luthando appointment; and one patient was transferred to a Life Esidemeni 
placement facility with no recorded follow up appointment scheduled.  
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The final sample consisted of 98 HIV positive, ART naïve patients, presenting with 
psychiatric symptoms, admitted to hospital and initiated on ART whist in hospital, then 
subsequently discharged to follow up at the Luthando clinic as out-patients. (Fig 4.1) 
 
Figure 4.1 Flow chart outlining all new patient clinic appointments at the Luthando 
Neuropsychiatric clinic for the period 1 July 2009 – 31 December 2010 
 
4.1.1 Demographic data of the sample 
Of the total sample of 98, the majority of the patients were female (76.53%) (n = 75). The 
mean age ± standard deviation of the sample was 34.85 ± 8.89 years, with males being 
slightly older than females (37.07 ± 10.55 years vs. 34.04 ± 8.23 years) (unpaired t test, t = 
1.63, 96 d.f, p = 0.11). The oldest patient was 62, and the youngest 18 years old. 
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Most of the sample were unemployed, accounting for 88.78% (n = 87) of the sample. 
However, only 23.47% (n = 23) of the sample were on a disability grant. The majority 
(66.36%) (n = 65) of the sample were single, with 28.57% (n = 28) being married or having a 
life partner, and thus described as being in a current relationship. The mean ± standard 
deviation for the number of years of schooling for the sample was 9.76 ± 2.49 years. There 
were three patients with a tertiary level of education. Of the total sample, 62.24% lived within 
15km of the clinic. 
 
4.2 Rate of Attendance 
The rate of attendance was 79.59% (n = 78), including full attendance and partial attendance 
on follow up appointment date. The rate of partial appointment attendance (attending within 
one month of appointment) was 26.53% of the total sample (n = 26) and full attendance was 
53.06% (n = 52).  Non-attendance was recorded in 20.41% of the total sample (n = 20) (fig 
4.2) 
 
  
 
Figure 4.2 Rate of attendance 
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4.3 Comparison of Data: Attendant vs. Non-Attendant Groups 
The comparison between the two groups, attendant vs. non-attendant revealed that the groups 
were fairly similar in terms of demographic data and clinical data. The groups did not differ 
significantly, in terms of gender, employment status, disability grant, poly-therapy/mono-
therapy, stage of HIV diagnosis, length of hospitalisation as well as time from discharge to 
follow up appointment. Both groups were predominantly female (Fisher‟s exact, RR1.12, 
95% CI 0.81-1.52, p = 0.55), unemployed (Fisher‟s exact, RR 1.15, 95% CI 0.27-4.93, p = 1) 
and not on a disability grant (Fisher‟s exact, RR 0.74, 96% CI 0.33-1.62, p = 0.56).  Most of 
the patients in each group had WHO stage four illness (Fisher‟s exact, RR 0.97, 95% CI 0.76-
1.25, p = 1).  There was also no difference in patients prescribed mono-therapy vs. poly-
therapy psychotropic medication (Fisher‟s exact, RR 1.14, 95% CI 0.93-1.39, p = 0.31). 
(Table 4.1)  
 
The (n) values are stated in table 4.1 and where they differ from the total number of attendant 
and non-attendant, the difference can be accounted for by missing data.  All (n) values have 
been clearly stated exactly as they were used for statistical analysis.  
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Table 4.1 Comparison of demographic and clinical data of attendant vs. non-attendant groups    
Data 
 
Attendant 
(n=78) 
% Non-attendant 
(n=20) 
% p-value 
Age (years)- mean ±SD 35.65 ± 9.04  31.7 ± 7.7  0.08
b 
Female 61 78.21% 14 70.00% 0.55 
Unemployed 69 88% 18 90% 1.00 
Disability grant 17 (n=77) 22.08%  6 30% 0.56 
School Education (years) 
– mean ±SD 
9.51±2.65 
(n=64) 
  10.8±1.21 
(n=15) 
 0.08
a 
Poly-therapy 42 (n=77) 54.54%  14 70% 0.31 
Substance use history 16 (n=72) 22.22%  7 (n=16) 43.75%  0.11 
HIV status not disclosed  6 (n=40) 15%  6 (n=11) 54.55%  0.01
* 
WHO stage four 49 71.01% 
(n=69) 
13 68.42% 
(n=19) 
1.00 
Current partner 26 33.33%  2 10% 0.05 
Length of hospitalisation 
(days) –mean ±SD 
37.95 ± 23.75  40.4 ± 20.9  0.42
a 
Time from discharge to 
follow up (days)- mean 
±SD 
14.86 ± 8.53  13 ± 6.88  0.45
a 
p-values calculated using Fisher‟s exact unless otherwise stated; a= Mann-Whitney test; 
b=unpaired t-test; * =significant. 
 
4.3.1 Psychiatric diagnosis 
Completion of data on psychiatric diagnosis was complicated by the presence of differential 
diagnosis in 51% of the sample. It was not clearly stated in any of these files which diagnosis 
the clinician considered to be the most likely of the differential diagnosis. Only 49% of the 
sample was labelled with one clear diagnosis, while 36.72% were given two differential 
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diagnoses, and 14.28% had three differential diagnoses stated. The average number of 
diagnoses/patient was 1.65. There were no differences between the two groups in terms of 
being given only one vs. more than one diagnosis. (Fisher‟s exact, RR 0.99, 95% CI 0.81-
1.21, p = 1) The average number of differential diagnosis in the attendant group was 1.30 
diagnoses/person, compared to 1.75 diagnoses/person in the non-attendant group. 
 
The most common differential diagnosis overall was psychotic disorder due to HIV (68 
patients), followed by mood disorder due to HIV (31 patients), followed by bipolar disorder 
(not specified I or II) (20 patients). In the 49% labelled with only one diagnosis, the most 
common diagnosis was still psychotic disorder due to HIV (19 patients), however, the second 
most common diagnosis was bipolar disorder (14 patients) followed by schizophrenia and 
major depressive disorder (five patients). The most common diagnosis in both groups, 
attendant and non-attendant, was psychotic disorder due to HIV. There was no difference 
between the two groups in terms of differential diagnosis when divided into two categories; 
“Primary psychiatric diagnosis” and “Psychiatric diagnosis due to general medical condition 
(HIV or medical illness). (Fischer‟s exact, RR 0.88, 95% CI 0.72-1.07, p = 0.21). The data 
was analysed in two categories as there were a number of small values in the specific 
diagnosis categories which made a statistical analysis invalid. The distribution of diagnoses is 
shown in table 4.2. 
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Table 4.2 Outline of attendant vs. non-attendant groups by psychiatric diagnosis  
 
4.3.2 IHDS score  
The variable which was missing most often on review of the files was the IHDS score. In 
those with recorded IHDS score, there was no difference between attendant and non-
attendant (Fisher‟s exact, RR 0.91, 95% CI 0.57-1.45, p = 1). Towards the end of the period 
under review, the IHDS score was being routinely recorded in the Luthando file, but prior to 
Diagnosis  Total % Attendant % Non-
attendant 
% 
Primary 
Psychiatric 
diagnosis 
 49 30.25% 35 27.56%  14 40%  
 Schizophrenia 8 4.94% 5 3.94%  3 8.57%  
 Schizoaffective 
disorder 
1 0.62% 0 0 1 2.86%  
 Bipolar disorder 20 12.34% 15 11.81% 5 14.29% 
 Major depressive 
disorder 
9 5.56% 8 6.30%  1 2.86%  
 Substance induced 
Psychotic 
disorder 
11 6.79% 7 5.51%  4 11.43% 
Psychiatric 
diagnosis 
due to HIV 
/medical 
illness 
 113 69.75% 92 72.44%  21 60%  
 HIV associated 
neurocognitive 
disorder 
7 4.32% 5 3.94%  2 5.71%  
 Psychotic 
Disorder Due to 
GMC-HIV 
68 41.98% 55 43.31% 13 37.14% 
 Psychotic 
Disorder Due to 
GMC-other 
7 4.32% 6 4.72%  1 2.86%  
 Mood disorder 
due to GMC-HIV 
31 19.14% 26 20.47%  5 14.29%  
Total  162  127  35  
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this, was recorded only if the clinician felt it was significant with regards to current 
management issues. The IHDS score was missing in 77.56% of the total sample. (Table 4.3) 
 
Table 4.3 Comparison of IHDS score in attendant vs. non-attendant groups 
IHDS score Attendant 
(n=19) 
Non-attendant 
(n=3) 
p value  (Fischer‟s exact) 
<10 4 1 p=1 
>9 15 2  
 
4.3.3 Age 
The mean age of the attendant group (35.65 ± 9.04) was slightly older than the non-attendant 
group (31.7 ± 7.7) although not significant (Unpaired t test, t = 1.79, 96 d.f., p = 0.08).  
 
4.3.4 Level of education 
The non-attendant group (mean 10.80 ± SD 1.21) had a higher mean level of school 
education than the attendant group (mean 9.51 ± SD 2.56) (Mann-Whitney, p = 0.08) (Table 
4.1) There were only three patients in the entire sample with a tertiary level of education, one 
attendant (n = 69) and two non-attendant (n = 16) (Fisher‟s exact, RR 2.49, 95% CI 0.50-
12.37, p = 0.09)  
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4.3.5 Substance use history 
A history of substance use was recorded in 23.47% of the overall sample. In 10.20% of files 
reviewed, a substance use history had not been documented by any of the treating clinicians, 
suggesting there had been no enquiry into substance use during hospitalization in these 
patients. A history of substance use was more common in the non-attendant group (43.75%) 
vs. the attendant group (22.22%) although not significant (Fisher‟s exact, RR1.24, 95% CI 
0.93-1.65, p = 0.11). (Fig 4.3) 
 
 
Figure 4.3 Percentage of attendant (n=72) vs. non-attendant (n=16) patients with a history of 
substance use (p = 0.11) 
 
4.3.6 Disclosure of HIV status 
The only factor in the bivariate analysis that was statistically significant was disclosure of 
HIV status (Fisher‟s exact, RR 0.28, 95% CI 0.11-0.69, p = 0.01). This category was 
recorded as “disclosed” if the patient‟s treatment supporter was aware of the HIV diagnosis. 
The category “disclosure of HIV status” relied on an additional note from the treating 
clinician stating of the patient had disclosed their HIV status to the treatment supporter. Each 
0%
20%
40%
60%
80%
100%
no yes
Percent  
Substance use history 
attendant
non-attendant
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patient had a documented treatment supporter in order to be considered for ART. However, it 
was not mandatory that the treatment supporter knew the details of the “treatment” and the 
“diagnosis”. In certain files it was clearly stated “not disclosed” and in others, “disclosed 
to…” However in 47.96% of the sample, it was not stated clearly if the diagnosis had been 
disclosed to the treatment supporter. (48% of attendant vs. 45% of non-attendant patients). 
The remainder of the files specified “disclosed” vs. “non-disclosed” next to the name of the 
treatment supporter, indicating that the treatment supporter was aware of the HIV diagnosis. 
Significantly fewer of the non-attendant group (15%) had disclosed their HIV positive status 
to the treatment supporter than the attendant group (54.55%).  
 
Within the category “disclosure”, data was further divided into sub-categories based on who 
the patient had disclosed their HIV status to, family or friend. (Fig 4.4). There was no 
significant difference between the two groups in terms of disclosure to friend or family. 
(Fisher‟s exact, RR 1.78, 95% CI 0.44-7.17, p = 0.24) 
 
 
Figure 4.4 Percentage of attendant vs. non-attendant patients who had disclosed HIV 
seropositive status to friend or family 
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4.3.7 Marital status 
The data collected with regard to Marital status was grouped for analysis into two groups, 
“Current Partner”, including the patients who were married or had a life partner,  and “No 
Current Partner”, which consisted of patients who were single, or widowed, or divorced. Less 
non-attendant patients had a current partner (10%) than attendant patients (33.33%), although 
not statistically significant (Fisher‟s exact, RR 3.33, 95% CI 0.86-12.89, p = 0.05). Data was 
grouped for final analysis as the numbers were too small to perform a valid analysis on each 
subcategory independently. (Table 4.4) 
 
There was no association between being in a current relationship and disclosure of HIV 
status. (Fisher‟s exact, RR 0.99, 95% CI 0.67-1.41, p = 1) 
 
Table 4.4 Comparison of marital status in attendant vs. non-attendant groups 
Marital status Attendant 
(n=78) 
% Non-attendant 
(n=20) 
% 
Divorced/widowed 4 5.13%  1 5% 
life partner 6 7.69%  1 5% 
Married 20 25.64% 1 5% 
Single 48 61.53% 17 85%  
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4.3.8 Length of hospitalisation 
The average length of hospitalisation was 39.89 days. There was no significant difference in 
the length of admission to hospital between attendant (mean 37.95 ± SD 23.75) and non-
attendant groups (mean 40.40 ± SD 20.90). (Mann-Whitney test, p = 0.42) The maximum 
length of stay in the attendant group was 93 days vs. 127 days in the non-attendant group. 
(Table 4.1) 
 
4.3.9 Time from discharge to follow up appointment 
There was no significant difference between the attendant (mean 14.86 ± SD 8.53) and non-
attendant groups (mean 13 ± SD 6.88) in terms of time from discharge to follow up 
appointment date. (Mann-Whitney test, p = 0.45) (Table 4.1)  The average length of time 
from discharge to follow up appointment date was 14.48 days, indicating that on average, 
patients were scheduled for a follow up appointment approximately two weeks after 
discharge from hospital.  
 
4.3.10 Distance from clinic 
There was no significant difference between attendant and non-attendant patients in a 
grouped analysis of those living within 10km of the clinic. (Fisher‟s exact, RR 1.58, 95% CI 
0.66-3.78, p = 0.37) (Table 4.5) 
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Table 4.5 Comparison of distance from clinic in attendant vs. non attendant groups 
Distance  Attendant (n=62) % Non attendant (n=14) % Fisher‟s exact 
< 10 km 34 54.84% 10 71.43% P = 0.37 
≥ 10 Km 28 45.16% 4 28.57%  
 
4.4 Summary of Results 
The rate of attendance for the sample at the clinic post discharge from hospital was 79.59%. 
The sample was predominantly female. There were a number of similarities between the 
attendant and non-attendant groups in terms of demographic and clinical data.  The only 
statistically significant variable was disclosure of HIV status, and attenders were significantly 
more likely to have disclosed their HIV status to the treatment supporter.   
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CHAPTER FIVE: DISCUSSION 
5.1 Rate of Attendance 
The rate of attendance at the first clinic appointment post discharge from hospital was 
79.59%. The reason for non-attendance (20.41%) was not ascertained in this study, and most 
likely included those that had discontinued ART treatment, were too unwell to return for 
follow up appointments, moved to a different area and therefore changed clinics, as well as 
those that died within the time from discharge to follow up appointment (2,37,38,39). To my 
knowledge, there are no similar figures for attendance at other neuropsychiatric clinics after 
in-patient initiation of ART, following psychiatric hospitalisation with which to compare this 
rate from South African or international data. A possible explanation for the lack of similar 
data, representing HIV positive psychiatrically unwell patients is the nature of the Luthando 
Neuropsychiatric clinic, in that it provides a unique combination of in-patient and out-patient 
treatment for HIV as well as psychiatric treatment. 
 
International studies examining first clinic appointment attendance post discharge from 
psychiatric hospitalisation have not been consistent, with figures of attendance varying from 
82% to 36% in studies conducted in the USA (43,44). The rate of attendance in the current 
study fell within this large range.  Crompton et al (44) commented that their exceptionally 
high rate of non-attendance was out of keeping with previous similar studies, but not out of 
keeping with what they expected in their clinical setting based on prior observation. They 
suggested several reasons for their high rate of non-attendance including the severity of 
psychiatric presentations and high rates of unemployment in their sample (44). In the current 
study, in addition to the psychiatric presentation it is important to remember the significance 
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of the HIV diagnosis with regards to outcome after hospitalisation. HIV positive patients may 
be physically more unwell than the general psychiatric patient described in the studies by 
Kruse et al (43) and Crompton et al (44), which might impact on attendance.   
 
Boyles et al (1), in their study examining an ART initiation program designed for a low 
resource setting in the Eastern Cape, estimated their four year loss to follow up rate at 11.4%. 
They suggested that this represents a low rate of loss to follow up and might have been the 
result of some of the strengths of their program, including integrated in-patient care (1). 
Boyes et al (1) found a higher rate of LTFU specifically after in-patient initiation on ART as 
well as in pregnant women, and suggested three possible reasons for this finding. Firstly, they 
suggested the possibility that a decreased time before initiation of treatment and a decreased 
number of preparation sessions could be associated with high rates of LTFU (1). Time from 
diagnosis to initiation of ART was not examined in the current study, but it is possible that 
some patients had a longer pre-initiation period, with more extensive pre-initiation adherence 
counselling. Secondly, Boyes et al (1) suggested that patients who present with HIV due to 
illness and not because of a concern regarding exposure may be more likely to be LTFU. 
They support this hypothesis by referencing Maqutu et al (60) who found an increased rate of 
“optimal adherence” in those patients who presented for HIV testing due to feared exposure 
compared to those who were tested because they were unwell (1). There may be links 
between illness awareness, insight into risk of infection, insight into need for treatment and 
subsequent adherence to treatment (60). This may have been a relevant factor influencing the 
rate of attendance in the current study as all the patients presented primarily with a 
psychiatric diagnosis and not for HIV testing due to feared exposure. It is possible that 
hospitalization due to a psychiatric presentation may suggest that a patient‟s primary focus 
was not on HIV testing and need for ART treatment, which may impact on attendance and 
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subsequent adherence. Thirdly, Boyes et al (1) postulated that peri-partum depression may 
have accounted for some of the increased rate of LTFU in the pregnant group. Boyes et al (1) 
quoted several previous studies which have linked depression to non-adherence to ART, and 
postulated that there might have been a possible high overall prevalence of post-partum 
depression in their study, in the pregnant group. Notably, it does not seem that depression 
was screened for in their study, and no comment on the level of peri-partum depression was 
reported, thus this direct link was not supported by the data presented in the article reviewed 
(1). However, there is some evidence linking depression to non-adherence and non-
attendance in the literature and this will be discussed separately (3,5,7,25,26). Although there 
was a female predominance overall in the current study, and depression was independently 
examined as a possible association with attendance, it was not recorded if a patient presented 
in the peri-partum period and thus no link was investigated between peri-partum depression 
and attendance.  
 
Eshun-Wilson et al (2) found a higher rate of loss to follow up, over a 6 month period of 35% 
in their case control sample of HIV positive patients, hospitalised for a medical illness, 
initiated on ART in South Africa. They hypothesised that this high rate of LTFU might have 
in part been due to death, and suggested that unrecorded death accounts for a significant 
proportion of patients classified as lost to follow up in HIV treatment centres (2). They found 
that hospitalised patients initiated on ART were more likely to die or be lost to follow up than 
out-patient controls. They defined loss to follow up for their study as failure to return to clinic 
for a period of three months or more. Their study was limited by a small sample size (2). It is 
possible that the current study sample was not as medically unwell as the sample in the study 
by Eschun-Wilson et al (2), as in general, frail medically unwell patients are not admitted to 
the psychiatric wards at CHBAH, although, medical co-morbidity was not recorded in this 
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study. It should also be noted that four medically unwell patients who were initially admitted 
to the psychiatric wards and attended the Luthando clinic for ART assessment, subsequently 
deteriorated physically and were transferred to a general medical ward and lost to follow up 
and excluded from analysis. (Fig 4.1) It is therefore possible that the incidence of death in the 
first month post discharge from hospital in the current study population might have been 
lower than that recorded in general HIV clinics if patients LTFU were traced to determine 
reason for LTFU.   
 
5.2 Gender 
There was no significant difference between the attendant and non-attendant groups in terms 
of gender, however the majority of the sample were female (76.53%), with a ratio of female 
to male in the sample of 3.3. The mid-year South Africa national statistics for 2011 (61) 
estimated a female to male HIV prevalence ratio at 1.5 in South Africans between the ages of 
15-49. The ratio found in this study was notably greater than the estimated ratio for the 
population of South Africa. The reason for the female predominance in this study is unclear; 
however other studies at ART centres in South Africa have found a female predominance 
ranging from 62.8% to 71% in similar regions within South Africa (45,62). This is in contrast 
to a previous report from a random sample of psychiatric admissions at CHBAH in 1996, 
where there was a distinct male predominance with females only representing 35.6% of the 
sample (63).  
 
In their review article, Akerman and de Klerk (64) outlined the variables thought to play an 
important role in increasing the risk of HIV infection in females in the South African context. 
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These factors include biological factors, related to the female anatomy, as well as a number 
of psycho-social factors which have been shown to impact rates of transmission and 
vulnerability to HIV infection (64). With regards to societal factors, in a technical report to 
the Australian agency for international development, Dunkle et al (65) investigated rates of 
“gender based violence” among women attending an antenatal clinic in Soweto. The authors 
suggested a link between exposure to gender based violence and HIV infection in women 
(65). The study found high rates of reported physical abuse (50.4%) and sexual abuse 
(20.1%) among respondents, with 55.5% of respondents reporting a lifetime history of 
physical or sexual assault by a male partner (65). Furthermore they found an association 
between partner violence, perception of control in a relationship and HIV status (65). Dunkle 
et al (65) made reference to a review article by Campbell et al (66) examining “intimate 
partner violence” and HIV infection. In this review, Campbell et al (66) summarised factors 
thought to play a role in the link between gender based violence and increased susceptibility 
to HIV infection; firstly, the biology around forced sex, with “traumatic penetration” further 
increasing the risk of transmission to females, secondly, the influence of violence towards 
women on sexual decision making, such as safe sex practices like condom usage; thirdly, an 
association between sexual abuse and subsequent high risk sexual behaviour increasing risk 
of HIV infection including substance use; and fourthly, the long term effect of chronic abuse 
on physical and psychological well-being possibly increasing susceptibility to HIV infection, 
citing high levels of depression and anxiety among those exposed to chronic gender based 
violence (65,66,67). High rates of “transactional sex” may also increase female vulnerability 
to HIV infection in Soweto, and thus might have influenced the predominantly female 
presentation in the current study (67). 
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In a review of the issues around mental illness in people living with HIV/AIDS, Brandt (68) 
suggested an increase in risk for psychiatric conditions in females with HIV, compared to 
males with HIV, which may have played a role in the female predominance in the current 
study. Brandt (68), however, did not explore the reasons for this discrepancy.  
 
It is also possible that in general there may be fewer men who agree to test for HIV. 
Venkatesh et al (69) reported that 64.8% of women compared with 28.9% of men in a sample 
surveyed in Soweto had ever been tested for HIV.  Similarly, Mhlongo et al (70) found that 
71% of men in a cross sectional sample in Soweto had never tested for HIV. It is possible that 
fewer men in the psychiatric wards are referred for, or agree to, HIV testing at CHBAH. This 
might have played a role in the female predominance noted in the current study.   
 
5.3 Employment 
There was a high rate of unemployment in the sample with 88% of the sample being 
unemployed. This rate was much higher than previously reported unemployment rates in non-
psychiatric ART roll out sites in Soweto of 41% (62). However, the rate of unemployment 
was closer to that reported for a psychiatric population in Soweto of 93%, with rates of 
employment previously found to be 17.8% in psychiatric admissions at CHBAH (63,71). The 
unemployment rate in Soweto was estimated by the Soweto Development Plan to be around 
53% (72). It is possible that the psychiatric diagnosis in the sample impacted on ability to 
sustain employment.  
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Only 23% of the sample had access to a disability grant, suggesting the possibility of 
financial barriers to attendance in a significant proportion of the sample. This was slightly 
higher than a previous report of disability grant access in psychiatric admissions at CHBAH 
of 17.8% in 1996 (63).  Although there was no significant difference in unemployment rates 
or disability grant status between attendant and non-attendant groups, the high rate of 
unemployment overall and possible resultant financial constraints might still impact on 
outcome, as has been previously suggested, and should be investigated at each clinic visit 
(73).  
 
5.4 Disclosure of HIV Status 
The only significantly difference between the attendant and non-attendant groups was 
disclosure of HIV status, with non-attendance being associated with non-disclosure of HIV 
status. It was a requirement prior to initiation of ART that patients had a treatment supporter, 
and the intake history sheet contained the name of a treatment supporter. It was not standard 
however that the treatment supporter was aware of the diagnosis at the time of initiation of 
ART.  The finding in this study that disclosure of HIV status is significantly associated with 
clinic attendance is consistent with the findings in several previous African studies examining 
adherence to ART (7,33,34). 
 
It has been recommended that patients should have disclosed to one significant friend or 
family member or joined a support group prior to initiation of ART (27). The Luthando clinic 
has several support groups running and patients are actively encouraged to attend support 
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groups and adherence counselling sessions prior to initiation of ART. Consequently 
disclosure is not always insisted on by the treating team.  
 
Reasons for non-disclosure were not examined in this study, but have been previously 
extensively studied. A qualitative South African study in 2006 investigated patient and 
provider perceptions of support strategies influencing ART adherence, with participants 
recognising stigma related to disclosure of HIV status as a significant barrier to adherence 
(27). Key concepts which emerged from the patients in the qualitative South African study 
included concepts around safe disclosure. Participants felt safe disclosing to someone ““who 
will not reject you”, “will not discriminate against you”, will “help you cope with the 
disease” and will help “take HIV medication at the right times””. (27, p.130). Other patients 
mentioned fear of being “outed” to the community as being HIV positive by the person 
disclosed to as a reason for non-disclosure (27). Furthermore, gender based violence and 
subsequent disempowerment of women may influence behaviour related to disclosure of HIV 
status among women in Soweto (65,66).  
 
Calin et al (28) examined disclosure among HIV positive black African patients in London. 
Disclosure was prompted by a close trusting relationship, associated with the belief that there 
would be a supportive outcome (28). The most common reason for non-disclosure was ““not 
wanting to cause worry”” (28, p.388) followed by the idea that the diagnosis would be seen 
as a death sentence by those disclosed to. Interestingly, the mostly immigrant population 
cited commonly held beliefs around being HIV positive in Africa as a reason for non-
disclosure, with one participant stating ““if you live at home, you are dead already””. (28, 
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p.388).  There was also a fear of rejection, and a fear that the person they disclosed to would 
tell others (28).  
 
The patients in the current study not only had the stigma associated with HIV infection to 
bear, but also that of having a “mental illness” diagnosis. Therefore, rates of non-disclosure 
would have been expected to have been higher in this population than in a general HIV 
infected sample. Stigma has been reported extensively in psychiatric populations (31,32). 
Although to my knowledge there are no studies examining disclosure of psychiatric diagnosis 
by patient to family or friends and relationship to adherence, stigma regarding psychiatric 
illness may influence an individual decision to disclose a psychiatric diagnosis. Subsequent 
lack of support and encouragement may influence clinic attendance. 
 
It seems from previous research that disclosure of HIV status, if not met by rejection, serves 
the purpose of providing the patient with emotional and physical support, as well as someone 
to remind the patient to attend the clinic and to encourage adherence to the treatment regime 
(27). It is therefore important that non-disclosure of HIV status proved to be the only 
significant association with non-attendance at clinic. 
 
5.5 Marital Status 
Overall, the majority of the sample was currently single, with only 28.57% of the sample 
being in a current relationship. This was in keeping with previously reported figures from a 
selection of Psychiatric clinics in Soweto of 21.6% (71). 
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There were a larger percentage of attendant patients who were in a current relationship than 
non-attendant patients although this was not quite significant. There was no statistical 
association between being in a current relationship and disclosure of HIV status in the current 
study, but this may have been influenced by the small sample size. The previously described 
link between being in a current relationship and improved attendance may be related to the 
level of support, rather than being in a relationship, based on findings in previous studies 
(50,51). Bofill et al (50) found poor attendance at psychiatric out-patient clinics to be 
associated with limited family support. Similarly, in HIV clinic attendance, Catz et al (51) 
found non-attendance to be associated with lower perceived social support. 
 
5.6 Substance Use 
Although a history of substance use was more common in the non-attendant group this 
finding was not statistically significant. The current study did not look at substance use in 
detail in terms of which drugs were being used. There was also no objective evidence for 
substance use, and the study relied on a self-report history of substance use. Self report may 
lead to lower estimates of substance use within the sample due to patients wanting to impress 
clinicians with reports of abstinence (5). Overall, substance use was recorded in 23.5% of 
patients. In her review of the mental health of people living with HIV in Africa, Brandt (68) 
suggested that 7-16% of HIV positive patients in the research reviewed either abused or were 
dependent on substances, including alcohol. The South African Stress and Health study found 
a lifetime prevalence of substance use disorders in Gauteng of 13.3%, but 38.7% of people 
surveyed overall reported alcohol use (74,75). Furthermore, in a study of Psychiatric 
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admissions to Stikland hospital in the Western Cape, 51% of admissions were diagnosed with 
a co-morbid substance use disorder (76). In the current study, it is interesting to note that in 
addition to a low rate of substance use reported, a substance use history was not obtained at 
all in 10.2% of patient‟s records. This may suggest that not all clinicians view substance use 
as a potential problem worth screening for in the HIV positive psychiatric patient and are thus 
potentially under-diagnosing substance use disorders. This is especially significant as 
previously it has been shown that current substance abuse is associated with poorer adherence 
to ART and thus poorer overall long-term outcome (5,77).  
 
5.7 Age 
The attendant group were slightly older then the non-attendant group although not 
statistically significant. Previously, older age was found to be associated with ART clinic 
attendance (50,51). Catz et al (51) hypothesised that non-attendance and age may be related 
because of inexperience or lack of previous medical contact, as well as a feeling of 
invulnerability to death. 
 
5.8 Education Level 
The current study showed a non-significant, slightly higher mean level of school education in 
the non-attendant group.  This is out of keeping with what has been found in previous studies, 
showing lower levels of education in non-adherent patients in ART treatment settings, as well 
as lower “health literacy” levels (78).  Lower health literacy was also previously associated 
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with fewer years of education (78). The significance of education level in this study may have 
been limited by the small sample size. 
 
5.9 Psychiatric Diagnosis  
Previous literature has shown a significant association between poor adherence and 
depression, bipolar disorder and HAND (3,4,5,7,8). It was hypothesised that there would be 
an association between these diagnoses and poor attendance. However, it was not possible to 
demonstrate any associations with individual psychiatric conditions and adherence in the 
current study due to the small numbers involved in each psychiatric condition, particularly in 
the non-attendant group. Overall there were a high proportion of patients with a psychotic 
presentation with relatively fewer patients overall diagnosed with a major depressive episode. 
A possible explanation of this finding is the bias created by selecting hospitalized psychiatric 
patients for the study, which would already suggest a psychiatric presentation which is severe 
enough to warrant hospitalisation. A report on psychiatric admissions to CHBAH in 1996, 
which was before the national “roll-out” of antiretroviral therapy, suggested the most 
common diagnoses in their sample were schizophrenia and bipolar disorder (63). In their 
study, Behr et al (63) found 48.3% of patients presented with a psychotic illness namely 
schizophrenia or “other psychotic disorder”, with only 7.8% presenting with a major 
depressive episode. It should be noted that in 1996, psychotic disorder due to HIV was an 
emerging concept and did not appear among the listed diagnoses of their sample. 
 
As the IHDS score was not routinely performed in this sample, it is possible that screening 
for HAND may not have been adequate, thus underestimating the prevalence of HAND in the 
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sample, and possibly influencing the findings in terms of lack of association of HAND with 
attendance.   
 
5.10 Length of Admission and Time from Discharge to 
Follow-up Appointment 
The average length of stay was 39.89 days, which is similar to the finding by Behr et al (63) 
of an average length of admission to a psychiatric ward at CHBAH in 1996 at 37 days. In 
1996 however, the impact of HIV on psychiatric admissions was yet to be seen, and it is not 
clear what the average length of admission was in a psychiatric ward at CHBAH in 
2009/2010. There was no difference between attendant and non-attendant groups in terms of 
length of admission. This was in contrast to the finding by Crompton et al (44) in their 
psychiatric population followed up after psychiatric hospitalisation, where a shorter duration 
of hospitalisation was associated with non-attendance.  
 
The mean time from discharge to follow up appointment was 14.48 days. There was no 
difference between attendant and non-attendant groups. Kruse et al (43) found that patients 
were more likely to attend appointments scheduled within two weeks after psychiatric 
hospitalisation. Similarly, Crompton et al (44) found that non-attendant psychiatric out-
patients had a longer mean time from hospital discharge to follow up appointment.   
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5.11 Distance to the Clinic 
Although there was no reported difference between attendant and non-attendant groups in 
terms of distance to the clinic, Adulefosi et al (73) previously found that a higher proportion 
of schizophrenic patients who missed clinic appointments in Nigeria lived more than 20km 
away from the clinic. In a first world setting, reliance on public transport and lack of 
transportation to the clinic impacted on clinic attendance (37,56). One possible explanation as 
to why the current study found no association between distance from the clinic and 
attendance could have been that the majority of the sample (62.24%) actually lived within 
15km of the clinic. However, there is mixed evidence that distance from the clinic is 
important in attendance.  Eschun-Wilson et al (2) found no association between distance from 
the clinic and subsequent risk of loss to follow up.   
 
5.12 Limitations 
Although nearly 400 files were reviewed, only 98 were relevant for the current study. This 
figure was smaller than expected, and the percentage of non-attendant patients was even 
smaller. The small size of the non-attendant group provided difficulty in terms of the size of 
the sample and statistical analysis. Several variables might have possibly been significant in 
line with previous studies given a larger sample size 
 
Due to the retrospective nature of this study, completeness of data was dependent on 
physician record keeping at the time of initial contact with the patient. Several variables 
proved to be poorly recorded in the Luthando, CHBAH as well as out-patient psychiatric 
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files. The most noticeable of these was the data on IHDS score, which was missing in 77.56% 
of the sample. From review of the files, it seems that IHDS score was only recorded if a 
physician felt that there was neurocognitive impairment. However, this has possibly lead to 
an underestimation of neuro-cognitive deficits in the sample group. Towards the end of the 
study period, IHDS score was being routinely recorded.  
 
There were also no objective tools used to make psychiatric diagnosis, or to diagnose 
substance abuse, and the data was purely recorded from clinician‟s notes reporting substance 
use, or clinical diagnosis which was felt by the treating doctor to be most likely. Most 
patients had a differential diagnosis. It seems that clinicians were reluctant to commit to one 
diagnosis based on the clinical presentation. This made it difficult to compare groups based 
on psychiatric diagnosis. In terms of substance abuse, self-report may not be reliable, 
especially if current abuse may influence the clinician‟s decision to initiate ART and the 
patient is aware of this (5). Also, details regarding substance use were not recorded for this 
study, including duration of substance use, type of substance, route of administration, 
previous rehabilitation or impact on social and occupational function.  
 
There was no control group in this study with which to compare rate of attendance. This 
made it impossible to comment if the rate of attendance was high, low or average. There are 
no studies examining rates of out-patient clinic attendance in HIV positive mentally ill 
patients with which to compare the rates found in the current study.  
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However, taking into account financial and time constrains, this research report provided vital 
information with regards to the demographic profile of the psychiatric in-patients initiated on 
ART, highlighting high unemployment levels and suggesting a female predominance. The 
study has also highlighted system difficulties, reinforced the need for meticulous record 
keeping and brings to the fore potential targets for improvement in daily operations at the 
clinic, including treatment supporter interventions aimed at improving clinic attendance.   
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CHAPTER SIX: CONCLUSION  
HIV positive mentally ill patients initiated on ART as in-patients are capable of returning for 
out-patient follow up and continued out-patient ART. Non-disclosure of HIV status has been 
shown to be significantly associated with non-attendance and is likely a significant barrier to 
long term treatment adherence in this vulnerable mentally unwell, HIV positive population. 
This finding adds to the body of evidence linking disclosure of HIV status with adherence to 
ART, and now links non-disclosure specifically to out-patient clinic non-attendance in this 
population. 
 
Although this study did not examine the reasons for non-disclosure, stigma and fear of 
rejection are still a reality in the context of the HIV epidemic in South Africa, and likely 
influence the patient‟s decision not to disclose their HIV status. Psychosocial factors are often 
ignored by clinicians in favour of biological, or disease related barriers to adherence. This 
study once again highlights the importance of these psychosocial factors.  
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CHAPTER SEVEN: FURTHER RECOMMENDATIONS 
7.1 Clinical Implications and Recommendations 
Clinic protocols should encourage disclosure of HIV status within a safe environment, with 
adequate clinic as well as community support, recognising the potential for stigma and 
rejection within the community. This recommendation should be carried out within a broader 
public health framework aimed at de-stigmatising HIV within the community.  
 
The high female predominance in the sample population suggests a need to focus on 
women‟s health issues at the clinic including peri-natal input. From a public health 
perspective, interventions aimed at decreasing HIV transmission among women should be 
investigated. The HIV counselling and testing procedure for males admitted to psychiatric 
wards may need to be reviewed to ensure early diagnosis and access to care in this sub-group. 
 
There should be a re-emphasis on good clinical record keeping by doctors working in the 
clinic, documenting screening done at each encounter with a patient. Given the previous 
literature linking substance use and HAND with poor adherence and long term outcomes, 
screening for co-morbid diagnoses of HAND as well as substance use disorders should be 
routine. Objective measures such as urine multidrug testing as a screening tool for substance 
use, and the IHDS as a screening tool for HAND might be useful and increase sensitivity 
over clinical judgement and self-report. Even though these co-morbidities were not found to 
be significantly associated with attendance in this study, it should be noted that screening was 
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low and it is possible that the prevalence of HAND and substance use disorders was therefore 
underestimated.   
 
The high level of unemployment and relatively low level of access to social disability grants 
may suggest a need for increased involvement of allied disciplines such as occupational 
therapists in long term care of these patients. At a public health level, it may be useful to 
increase awareness of the occupational needs of this specific population, those with HIV and 
a psychiatric illness, at non-governmental workshops and sheltered employment centres. 
 
7.2 Recommendations for Future Research 
Future research arising from this study could focus on investigating reasons for non-
disclosure, subsequently leading to development and implementation of strategies to 
encourage disclosure. Tracing patients lost to follow up at the clinic, with face to face 
interviews might aid in determining patients rationale for non-attendance. This would 
obviously need to take into account ethical considerations with regards to confidentiality and 
patient willingness to participate in research. 
 
Research could also further investigate the role of psychiatric illness in attendance, by 
prospectively comparing rates of clinic attendance and loss to follow up in HIV positive 
patients with and without a psychiatric diagnosis.  
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Another area of concern, and target for further research is the perception that ART should not 
be initiated in hospitalized “in-patients”. Future research would be useful to add to the 
evidence regarding rates of loss to follow up and attendance in patients initiated on ART as 
in-patients vs. those initiated as out-patients.   
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APPENDIX ONE: DATA SOURCE SHEET 
Demographic Data 
Subject Number:           
 
Age 
18 - 30 0 
30 - 50 1 
50 -65 2 
unknown 3 
 
Gender  
Male Female Unknown  
0 1 2 
 
Marital Status 
 
Employment 
Yes No Unknown 
0 1 2 
 
Disability grant 
Yes No Unknown 
0 1 2 
 
 
Education:   years 
Primary Secondary Tertiary Unknown  
Single  Widowed  Divorced Married  Life 
partner 
Unknown  
0 1 2 3 4 5 
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0 1 2 3 
 
Approximate Distance from CHBAH, by area 
<5km Including: 
Diepkloof,  
Orlando east, 
Orlando west,  
Devland, 
Klipspruit,  
Naturena 
0 
5-10km Including:                   Eldorado estate 
Klipriviersoog             Nancefield 
Olifansvlei                  Pimville 
Eldorado Park            Dhlamini 
Chiawelo                    Dube 
Mfolo                          Klipspruit west 
Meadowlands             Dobsonville 
Jabulani                     Jabavu 
Molapo                       Moroka 
Moletsani                   Orlando 
1 
10>15km Including:                    Lenasia 
Mapetla                       Protea North 
Protea South               Protea Glen 
Naledi                          Zola 
Tladi                            Emdeni 
Thulani                        Doornkop 
Bram Fischerville    
2 
15≤20 Including:  
Lenasia South             Lawley 
Finetown 
3 
>20 Including 
Orange Farm 
4 
Other   5 
Unknown   6 
 
Admission details and clinic attendance 
Date of Admission:         
Date of Discharge:          
 
Length of admission 
<2 weeks 2 weeks-1 month 1-2months >2months Unknown 
0 1 2 3 4 
 
Appointment Date:         
 
Time from discharge to follow up appointment date 
≤1 week 1week<2weeks 2weeks≤1month >1month Unknown 
0 1 2 3 4 
Adherent (Attendance at clinic on appointment date)? 
Yes No Unknown 
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0 1 2 
 
Partially adherent  (Attendance at another date within 1 month)? 
Yes No Unknown 
0 1 2 
 
Non Adherent  (Did not attend clinic within 1 month)? 
Yes No Unknown 
0 1 2 
 
Past psychiatric and medical history 
Current Psychiatric diagnosis 
Schizophrenia 0 
Substance induced psychotic disorder 1 
Psychotic disorder not otherwise specified 2 
Major depressive disorder 3 
Bipolar mood disorder 4 
HIV associated neurocognitive disorder 5 
Psychotic disorder secondary to GMC (HIV) 6 
Psychotic disorder secondary to GMC (other) 7 
Mood disorder secondary to GMC (HIV) 8 
Mood disorder secondary to GMC (Other) 9 
Diagnosis unclear 10 
Unknown  11 
 
Current psychotropic medication 
Monotherapy Polytherapy Unknown 
0 1 2 
 
Substance abuse history 
Yes No Unknown 
0 1 2 
 
 
 
 
HIV related data 
Disclosure 
Family member 0 
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Friend 1 
Unknown  2 
Not disclosed 3 
 
WHO Stage of HIV infection: 
Stage 1 0 
Stage 2 1 
Stage 3 2 
Stage 4 3 
Not recorded 4 
 
IHDS Score 
>10 0 
<10 1 
Unknown/NR 2 
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APPENDIX 2: PERMISSION TO CONDUCT RESEARCH 
AT CHRIS HANI BARAGWANATH ACADEMIC 
HOSPITAL 
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APPENDIX 3: ETHICS CLEARANCE CERTIFICATE 
 
